Stocks & Options Analysis

The Botox Killer – PMTI

June 5, 2009

PMTI We can call this the Botox killer. Palomar Medical Technologies today announced the FDA approval of their anti wrinkle laser device. Maxim Group analyst Anthony Vendetti estimated the device could add between $12.5 million and $40.0 million to Palomar’s 2010 revenues. (http://www.reuters.com/article/marketsNews/idINBNG35425620090605?rpc=44) My understanding from PMTI’s most recent 10 Q (http://sec.gov/Archives/edgar/data/881695/000088169509000016/form10q.htm) is that...
Read More »

Why I bought Nutrisystem

January 3, 2008

You are probably thinking; I don’t want to hear about NTRI, I lost money the last two quarters they announced! Here are my reasons I can’t wait until NTRI gives 4th quarter preliminary results and next quarter guidance. They will be reporting Q4 during the week of Feb 11th and I am expecting them...
Read More »

Why I bought Wellcare Health Plans

December 25, 2007

Wellcare – Ticker WCG We all know the story… October 24th Wellcare is raided by every state and federal agency. Investors & Mutual Funds hear the words fraud and run for the exits. On December 10th, Bruce Berkowitz of Fairholme Capital Management filed a SC 13G showing ownership of 17,465,200 (43% of the outstanding...
Read More »